phenobarbital has been researched along with propiconazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hester, SD; Moore, T; Nesnow, S; Ren, H; Ward, W | 1 |
| Currie, RA; Goetz, AK; Goodman, JI; Omiecinski, CJ; Peffer, RC | 1 |
2 other study(ies) available for phenobarbital and propiconazole
| Article | Year |
|---|---|
Discrimination of tumorigenic triazole conazoles from phenobarbital by transcriptional analyses of mouse liver gene expression.
Topics: Animals; Carcinogens; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Fungicides, Industrial; Gene Expression; Gene Expression Profiling; Hybridization, Genetic; Liver; Male; Mice; Oligonucleotide Array Sequence Analysis; Organ Size; Phenobarbital; Transcription Factors; Transcription, Genetic; Triazoles | 2009 |
Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of action.
Topics: Animals; Carcinogenicity Tests; Carcinogens; Cell Proliferation; Constitutive Androstane Receptor; Female; Fungicides, Industrial; Genes, Reporter; Hepatocytes; Hypnotics and Sedatives; Male; Mice; Neoplasms, Experimental; Organ Size; Phenobarbital; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Toxicogenetics; Triazoles; Weight Gain | 2014 |